Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral and vaginal isosorbide mononitrate versus oral propranolol for cervical ripening at term
IRCT20201003048910N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of isosorbide mononitrate and propranolol in cervical ripening (CR) (4 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Method of delivery, Time elapsed to 6 cm dilation and 9 more. Started Sep 2018; status: completed.
02
Drugs
isosorbide mononitratepropranolol
03
Conditions
cervical ripening (CR)
Beyond the preview
Go deeper on IRCT20201003048910N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201003048910N1.